Last 12 months
Inside the activity.
1 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2023 Filed Apr 1, 2024 20:48 UTC |
Battle Emma S.Director
|
OtherClass A Common Stock | 15 | $40.00 | $600.00 |
DisclosureSEC source: 0001062993-24-007585 · form4.xml · nonDerivative · entry 4 Battle Emma S. · CIK 0001769744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,686 F3 · shares: The Reporting Person received these shares pursuant to a dividend reinvestment by the Reporting Person's broker and without the Reporting Person's knowledge. The Reporting Person has disgorged to the Company the profits realized from a sale that took place on February 22, 2023. Read SEC document |
| March 09, 2023 Filed Mar 9, 2023 23:55 UTC |
Hatchett Steven KeithChief Product Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 21,155 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-006453 · form4.xml · derivative · entry 3 Hatchett Steven Keith · CIK 0001880182 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,602 Underlying: Class A Common Stock · 21,155 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 09, 2023 Filed Mar 9, 2023 23:55 UTC |
Hatchett Steven KeithChief Product Officer
|
SaleClass A Common Stock | 21,155 | $39.78 | $841,545.90 |
DisclosureSEC source: 0001062993-23-006453 · form4.xml · nonDerivative · entry 2 Hatchett Steven Keith · CIK 0001880182 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,368 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.58 to $40.04, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 09, 2023 Filed Mar 9, 2023 23:55 UTC |
Hatchett Steven KeithChief Product Officer
|
Exercise / conversionClass A Common Stock | 21,155 | $30.45 | $644,169.75 |
DisclosureSEC source: 0001062993-23-006453 · form4.xml · nonDerivative · entry 1 Hatchett Steven Keith · CIK 0001880182 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:56 UTC |
WOODBURY EDWINA DDirector
|
GrantClass A Common Stock | 15 | $39.74 | $596.10 |
DisclosureSEC source: 0001062993-23-006455 · form4.xml · nonDerivative · entry 1 WOODBURY EDWINA D · CIK 0001051405 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,724 F1 · shares: These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:34 UTC |
Lawrence Mark HChief Financial Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 18,041 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-005956 · form4.xml · derivative · entry 3 Lawrence Mark H · CIK 0001701170 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class A Common Stock · 18,041 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:34 UTC |
Lawrence Mark HChief Financial Officer
|
SaleClass A Common Stock | 26,144 | $40.80 | $1,066,675.20 |
DisclosureSEC source: 0001062993-23-005956 · form4.xml · nonDerivative · entry 2 Lawrence Mark H · CIK 0001701170 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,146 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.46 to $41.18, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:34 UTC |
Lawrence Mark HChief Financial Officer
|
Exercise / conversionClass A Common Stock | 18,041 | $30.45 | $549,348.45 |
DisclosureSEC source: 0001062993-23-005956 · form4.xml · nonDerivative · entry 1 Lawrence Mark H · CIK 0001701170 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC |
CHANG JOSEPH YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 24,400 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · derivative · entry 10 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,410 Underlying: Class A Common Stock · 24,400 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC |
CHANG JOSEPH YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 600 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · derivative · entry 9 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 600 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC |
CHANG JOSEPH YChief Scientific Officer
|
SaleClass A Common Stock | 25,000 | $40.77 | $1,019,250.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 5 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,234 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.31 to $41.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC |
CHANG JOSEPH YChief Scientific Officer
|
Exercise / conversionClass A Common Stock | 24,400 | $30.45 | $742,980.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC |
CHANG JOSEPH YChief Scientific Officer
|
Exercise / conversionClass A Common Stock | 600 | $30.63 | $18,378.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:36 UTC |
LUND STEVENDirector · Exec. Chairman of the Board
|
GiftClass A Common Stock | 9,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005958 · form4.xml · nonDerivative · entry 1 LUND STEVEN · CIK 0001033942 · Director · Exec. Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · By SJL NS-Holdings L.L.C. Disclosed balance after: 113,574 F1 · ownership.nature: SJL NS-Holdings is a family limited liability company which is owned and controlled by the Reporting Person and his immediate family. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:32 UTC |
CHANG JOSEPH YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · derivative · entry 8 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Class A Common Stock · 26,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:32 UTC |
CHANG JOSEPH YChief Scientific Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 42,485 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · derivative · entry 7 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 42,485 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:32 UTC |
CHANG JOSEPH YChief Scientific Officer
|
SaleClass A Common Stock | 68,485 | $40.44 | $2,769,533.40 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,234 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.80, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:32 UTC |
CHANG JOSEPH YChief Scientific Officer
|
Exercise / conversionClass A Common Stock | 68,485 | $30.63 | $2,097,695.55 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:46 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · derivative · entry 8 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:46 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
SaleClass A Common Stock | 600 | $40.97 | $24,582.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 5 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,784 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.91 to $41.02, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:46 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
SaleClass A Common Stock | 9,400 | $40.38 | $379,572.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 4 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,384 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 00:46 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
Exercise / conversionClass A Common Stock | 10,000 | $30.63 | $306,300.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 3 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:46 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 19,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · derivative · entry 7 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 19,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:46 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,513 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · derivative · entry 6 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 2,513 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:46 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
SaleClass A Common Stock | 21,513 | $41.38 | $890,207.94 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,784 F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.85 to $41.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 00:46 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
Exercise / conversionClass A Common Stock | 21,513 | $30.63 | $658,943.19 |
DisclosureSEC source: 0001062993-23-005210 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2023 Filed Feb 23, 2023 22:58 UTC |
Thomas James DChief Accounting Officer
|
SaleClass A Common Stock | 2,829 | $41.12 | $116,328.48 |
DisclosureSEC source: 0001062993-23-004638 · form4.xml · nonDerivative · entry 2 Thomas James D · CIK 0001784360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,928 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.12 to $41.14, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 23:06 UTC |
Battle Emma S.Director
|
SaleClass A Common Stock | 987 | $41.70 | $41,157.90 |
DisclosureSEC source: 0001062993-23-004643 · form4.xml · nonDerivative · entry 1 Battle Emma S. · CIK 0001769744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,659 Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 23:00 UTC |
LIPMAN ANDREW DDirector
|
SaleClass A Common Stock | 1,000 | $41.42 | $41,420.00 |
DisclosureSEC source: 0001062993-23-004640 · form4.xml · nonDerivative · entry 1 LIPMAN ANDREW D · CIK 0001184208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,393 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 22:58 UTC |
Thomas James DChief Accounting Officer
|
GrantClass A Common Stock | 9,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004638 · form4.xml · nonDerivative · entry 1 Thomas James D · CIK 0001784360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,757 Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 22:56 UTC |
Hatchett Steven KeithChief Product Officer
|
GrantClass A Common Stock | 10,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004636 · form4.xml · nonDerivative · entry 1 Hatchett Steven Keith · CIK 0001880182 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,368 Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 22:54 UTC |
Clark Chayce DavidEVP and General Counsel
|
GrantClass A Common Stock | 18,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004631 · form4.xml · nonDerivative · entry 1 Clark Chayce David · CIK 0001873048 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,378 Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 22:52 UTC |
Tang Connie Mang YeeChief Global Growth Officer
|
GrantClass A Common Stock | 13,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004624 · form4.xml · nonDerivative · entry 1 Tang Connie Mang Yee · CIK 0001855461 · Chief Global Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,324 Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 22:47 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
GrantClass A Common Stock | 53,064 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004616 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,784 Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 22:50 UTC |
Lawrence Mark HChief Financial Officer
|
GrantClass A Common Stock | 19,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004619 · form4.xml · nonDerivative · entry 1 Lawrence Mark H · CIK 0001701170 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,249 Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:18 UTC |
Hatchett Steven KeithChief Product Officer
|
Tax withholdingClass A Common Stock | 1,314 | $45.38 | $59,629.32 |
DisclosureSEC source: 0001062993-23-003831 · form4.xml · nonDerivative · entry 1 Hatchett Steven Keith · CIK 0001880182 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,117 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:20 UTC |
Thomas James DChief Accounting Officer
|
Tax withholdingClass A Common Stock | 1,295 | $45.38 | $58,767.10 |
DisclosureSEC source: 0001062993-23-003835 · form4.xml · nonDerivative · entry 1 Thomas James D · CIK 0001784360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,427 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:17 UTC |
Clark Chayce DavidEVP and General Counsel
|
Tax withholdingClass A Common Stock | 1,303 | $45.38 | $59,130.14 |
DisclosureSEC source: 0001062993-23-003829 · form4.xml · nonDerivative · entry 1 Clark Chayce David · CIK 0001873048 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,288 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:14 UTC |
CHANG JOSEPH YChief Scientific Officer
|
Tax withholdingClass A Common Stock | 1,981 | $45.38 | $89,897.78 |
DisclosureSEC source: 0001062993-23-003827 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,234 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:12 UTC |
Lawrence Mark HChief Financial Officer
|
Tax withholdingClass A Common Stock | 2,868 | $45.38 | $130,149.84 |
DisclosureSEC source: 0001062993-23-003825 · form4.xml · nonDerivative · entry 1 Lawrence Mark H · CIK 0001701170 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,350 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:10 UTC |
Tang Connie Mang YeeChief Global Growth Officer
|
Tax withholdingClass A Common Stock | 870 | $45.38 | $39,480.60 |
DisclosureSEC source: 0001062993-23-003823 · form4.xml · nonDerivative · entry 1 Tang Connie Mang Yee · CIK 0001855461 · Chief Global Growth Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,817 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:09 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
Tax withholdingClass A Common Stock | 6,963 | $45.38 | $315,980.94 |
DisclosureSEC source: 0001062993-23-003820 · form4.xml · nonDerivative · entry 1 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,720 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:18 UTC |
Hatchett Steven KeithChief Product Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,649 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-003831 · form4.xml · derivative · entry 2 Hatchett Steven Keith · CIK 0001880182 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,757 Underlying: Class A Common Stock · 5,649 shares Expires 2027-02-15 F2 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:20 UTC |
Thomas James DChief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 4,819 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-003835 · form4.xml · derivative · entry 2 Thomas James D · CIK 0001784360 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,821 Underlying: Class A Common Stock · 4,819 shares Expires 2027-02-15 F2 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:17 UTC |
Clark Chayce DavidEVP and General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,349 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-003829 · form4.xml · derivative · entry 2 Clark Chayce David · CIK 0001873048 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,739 Underlying: Class A Common Stock · 2,349 shares Expires 2027-02-15 F2 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:14 UTC |
CHANG JOSEPH YChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 17,692 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-003827 · form4.xml · derivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,810 Underlying: Class A Common Stock · 17,692 shares Expires 2027-02-15 F3 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:12 UTC |
Lawrence Mark HChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 24,919 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-003825 · form4.xml · derivative · entry 2 Lawrence Mark H · CIK 0001701170 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,041 Underlying: Class A Common Stock · 24,919 shares Expires 2027-02-15 F2 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:09 UTC |
NAPIERSKI RYAN SDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 37,751 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-003820 · form4.xml · derivative · entry 2 NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,831 Underlying: Class A Common Stock · 37,751 shares Expires 2027-02-15 F2 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| January 23, 2023 Filed Jan 23, 2023 23:58 UTC |
LIPMAN ANDREW DDirector
|
SaleClass A Common Stock | 1,000 | $42.27 | $42,270.00 |
DisclosureSEC source: 0001062993-23-001272 · form4.xml · nonDerivative · entry 1 LIPMAN ANDREW D · CIK 0001184208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,393 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Read SEC document |
| December 22, 2022 Filed Dec 22, 2022 22:50 UTC |
LIPMAN ANDREW DDirector
|
SaleClass A Common Stock | 1,000 | $40.75 | $40,750.00 |
DisclosureSEC source: 0001062993-22-024422 · form4.xml · nonDerivative · entry 1 LIPMAN ANDREW D · CIK 0001184208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,393 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.